Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide Compared to the Class IA Antiarrhythmic Drug Quinidine in Experimental Canine Atrial Flutter:

Journal of Cardiovascular Electrophysiology - Tập 7 Số 9 - Trang 809-827 - 1996
Yong‐Mei Cha1, Alan Wales, Patrick D. Wolf, S Shahrokni, Neil Sawhney, Gregory K. Feld
1Division of Cardiology, University of California, San Diego 92103, USA.

Tóm tắt

Effects of Dofetilide in Canine Atrial Flutter. Introduction: Previous studios that Class III antiarrhythmic drugs are more effective in reentrant arrhythmias because they prolong refractoriness (ERP) and wavelength and reduce dispersion of refractoriness compared to Class IA antiarrhythmic drugs, which slow conduction velocity (CV) in addition to their effects on refractoriness. Methods and Results: To test this hypothesis, the Class III drug dofetilide and the Class IA drug quinidine were studied in the experimental canine crush‐injury model of atrial flutter, utilizing right atrial multipoint programmed stimulation and activation mapping. In seven dogs dofetilide prolonged ERP by 23%, slowed CV by 9% at 200‐msec cycle length (P < 0.001) and by 39% at 150‐msec cycle length (P < 0.001), and increased wavelength by 11% (P < 0.02). Dofetilide reduced dispersion of ERP by 20% (P = 0.003) and adjacent electrodes with ERP difference ≥: 20 msec by 76% (P < 0.001). Dofetilide slowed atrial flutter by 37% (P = 0.003) prior to terminating and suppressing it in all dogs. In eight dogs quinidine prolonged ERP by 14% (P < 0.001), slowed CV by 14% at 200‐msec cycle length (P < 0.00) and by 19% at 150‐msec cycle length (P < 0.001), and reduced wavelength by 2% (P = NS). Quinidine did not reduce dispersion of refractoriness. Quinidine slowed atrial flutter by 57% (P < 0.001), terminating and suppressing it in only three dogs. Efficacy of dofetilide was greater than quinidine (P = 0.026) and correlated with reduced dispersion of ERP (r = ‐0.653, P = 0.01), reduced adjacent electrodes with ERP difference ≥ 20 msec (r = ‐0.637, P = 0.012), and prolonged wavelength (r = 0.61, P = 0.018). Dofetilide and quinidine terminated atrial flutter by similar mechanisms. Myocardial fiber orientation was nonuniform around the crush injury. Conclusions: Antiarrhythmic efficacy of dofetilide was greater than that of quinidine and correlated with drug‐induced prolongation of wavelength and reduction in dispersion of refractoriness, effects produced only by dofetilide.

Từ khóa


Tài liệu tham khảo

10.1056/NEJM198908103210608

10.1161/01.CIR.82.4.1106

Hine LK, 1989, Meta‐analysis of empirical long‐term antiarrhythmic therapy after myocardial infarction, JAMA, 262, 3037, 10.1001/jama.1989.03430210079035

10.1016/0002-9149(90)90856-V

10.1016/0002-8703(81)90036-3

10.1016/0002-8703(84)90368-5

10.1161/01.CIR.72.3.555

10.1161/01.CIR.69.3.577

10.1056/NEJM199308123290702

10.1161/01.CIR.74.1.197

Suttorp M, 1992, Efficacy andsafety of a new selective class HI antiarrhythmic agent dofetilide in patients with paroxysmal atrial fibrillation or atrial flutter, J Am Coli Cardiol, 19, 62A

10.1161/01.CIR.83.6.2067

10.1016/0735-1097(92)90115-4

10.1161/01.CIR.86.2.628

Gwilt M, 1991, UK‐68,798, a novel and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells, J Pharmacol Exp Ther, 256, 318

10.1016/0014-2999(92)90021-U

10.1111/j.1476-5381.1991.tb09828.x

10.1097/00005344-199009000-00008

Rasmussen H, 1994, Electropharmacological Control of Cardiac Arrhythmias: To Delay Conduction or to Prolong Refractoriness, 551

Carmeliet E, 1992, Voltage‐and time‐dependent block of the delayed K+ current in cardiac myocytes by dofetilide, J Pharmacol Exp Ther, 262, 809

10.1161/01.RES.62.2.324

10.1161/01.RES.62.5.1055

10.1161/01.CIR.82.1.274

10.1016/S0022-2828(86)80296-6

10.1152/ajpheart.1987.253.3.H704

10.1161/01.RES.65.6.1612

10.1161/01.RES.39.2.168

10.1016/0735-1097(93)90719-H

10.1161/01.RES.58.3.356

10.1161/01.CIR.84.3.1296

Williams EM, 1971, Cardiac Arrhythmias, 449

10.1002/j.1552-4604.1984.tb01822.x

10.1161/01.RES.62.2.395

10.1161/01.RES.41.1.9

10.1161/01.RES.65.6.1565

10.1161/01.RES.68.2.493

10.1161/01.CIR.84.3.1447

10.1111/j.1540-8167.1993.tb01230.x

Thông tin
Thông tin xuất bản

Journal of Cardiovascular Electrophysiology

Tập 7 Số 9

809-827

Thông tin tác giả